277 related articles for article (PubMed ID: 14733415)
1. Duration of optimal therapy for idiopathic focal segmental glomerulosclerosis.
Pokhariyal S; Gulati S; Prasad N; Sharma RK; Singh U; Gupta RK; Mittal S; Mehta B
J Nephrol; 2003; 16(5):691-6. PubMed ID: 14733415
[TBL] [Abstract][Full Text] [Related]
2. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
Dumoulin A; Hill GS; Montseny JJ; Meyrier A
Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
[TBL] [Abstract][Full Text] [Related]
3. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants.
Chun MJ; Korbet SM; Schwartz MM; Lewis EJ
J Am Soc Nephrol; 2004 Aug; 15(8):2169-77. PubMed ID: 15284302
[TBL] [Abstract][Full Text] [Related]
4. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
Mahmoud I; Basuni F; Sabry A; El-Husseini A; Hassan N; Ahmad NS; Elbaz M; Moustafa F; Sobh M
Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265
[TBL] [Abstract][Full Text] [Related]
5. Clinical and morphological predictors of renal outcome in adult patients with focal and segmental glomerulosclerosis (FSGS).
Shiiki H; Nishino T; Uyama H; Kimura T; Nishimoto K; Iwano M; Kanauchi M; Fujii Y; Dohi K
Clin Nephrol; 1996 Dec; 46(6):362-8. PubMed ID: 8982551
[TBL] [Abstract][Full Text] [Related]
6. Fractional excretion of IgG predicts renal outcome and response to therapy in primary focal segmental glomerulosclerosis: a pilot study.
Bazzi C; Petrini C; Rizza V; Napodano P; Paparella M; Arrigo G; Pisano L; D'Amico G
Am J Kidney Dis; 2003 Feb; 41(2):328-35. PubMed ID: 12552493
[TBL] [Abstract][Full Text] [Related]
7. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission.
Troyanov S; Wall CA; Miller JA; Scholey JW; Cattran DC;
J Am Soc Nephrol; 2005 Apr; 16(4):1061-8. PubMed ID: 15716334
[TBL] [Abstract][Full Text] [Related]
8. The long-term results of pediatric patients with primary focal and segmental glomerulosclerosis.
Sozeri B; Mir S; Mutlubas F; Sen S
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):87-92. PubMed ID: 20061699
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[TBL] [Abstract][Full Text] [Related]
10. Clinical course of primary focal segmental glomerulosclerosis (FSGS) in Turkish children: a report from the Turkish Pediatric Nephrology FSGS Study Group.
Beşbaş N; Ozaltin F; Emre S; Anarat A; Alpay H; Bakkaloğlu A; Baskin E; Buyan N; Dönmez O; Düşünsel R; Ekim M; Göko F; Gür-Güven A; Kavukçu S; Mir S; Sönmez F
Turk J Pediatr; 2010; 52(3):255-61. PubMed ID: 20718182
[TBL] [Abstract][Full Text] [Related]
11. Effects of angiotensin-converting enzyme inhibitor and steroid therapy on proteinuria in FSGS: a retrospective study in a single clinic.
Stiles KP; Abbott KC; Welch PG; Yuan CM
Clin Nephrol; 2001 Aug; 56(2):89-95. PubMed ID: 11522100
[TBL] [Abstract][Full Text] [Related]
12. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.
Heeringa SF; Branten AJ; Deegens JK; Steenbergen E; Wetzels JF
Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739
[TBL] [Abstract][Full Text] [Related]
13. Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis?
Ponticelli C; Villa M; Banfi G; Cesana B; Pozzi C; Pani A; Passerini P; Farina M; Grassi C; Baroli A
Am J Kidney Dis; 1999 Oct; 34(4):618-25. PubMed ID: 10516340
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic focal segmental glomerulosclerosis: a favourable prognosis in untreated patients?
Deegens JK; Assmann KJ; Steenbergen EJ; Hilbrands LB; Gerlag PG; Jansen JL; Wetzels JF
Neth J Med; 2005 Nov; 63(10):393-8. PubMed ID: 16301760
[TBL] [Abstract][Full Text] [Related]
15. [Factors predicting for renal survival in primary focal segmental glomerulosclerosis].
Roja JR; Pérez M; Hurtado A; Asato C
Nefrologia; 2008; 28(4):439-46. PubMed ID: 18662153
[TBL] [Abstract][Full Text] [Related]
16. Correlation of kidney biopsy findings and clinical manifestations of primary focal and segmental glomerulosclerosis.
Taheri D; Chehrei A; Samanianpour P; Hassanzadeh A; Sadrarhami S; Seyrafian S
Saudi J Kidney Dis Transpl; 2009 May; 20(3):417-23. PubMed ID: 19414944
[TBL] [Abstract][Full Text] [Related]
17. Intravenous pulse cyclophosphamide--a new regime for steroid resistant focal segmental glomerulosclerosis.
Gulati S; Kher V
Indian Pediatr; 2000 Feb; 37(2):141-8. PubMed ID: 10745408
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
Lee HY; Kim HS; Kang CM; Kim SG; Kim MJ
Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
[TBL] [Abstract][Full Text] [Related]
19. Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal.
Geary DF; Farine M; Thorner P; Baumal R
Clin Nephrol; 1984 Sep; 22(3):109-13. PubMed ID: 6488594
[TBL] [Abstract][Full Text] [Related]
20. Steroid therapy and prognosis of focal segmental glomerulosclerosis in the elderly.
Nagai R; Cattran DC; Pei Y
Clin Nephrol; 1994 Jul; 42(1):18-21. PubMed ID: 7923961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]